(Total Views: 267)
Posted On: 05/05/2022 7:05:10 PM
Post# of 1418
Does Pfizer only have 3 case studies with Paxlovid for LC? I guess maybe because it's a big risk prescribing a drug for something that isn't it's intended purpose?
If little Todos does one more, they are tied. With the two mentioned below that said their long COVID symptoms improved substantially, what does that mean? Did it ever go away?
Evidence mounts for need to study Pfizer's Paxlovid for long COVID - researchers say - Thu, May 5, 2022, 5:15 PM
CHICAGO (Reuters) - Additional reports of patients with long COVID who were helped by Pfizer Inc's oral antiviral treatment Paxlovid offer fresh impetus for conducting clinical trials to test the medicine for the debilitating condition, U.S. researchers said on Thursday.
Three new case studies follow earlier reports of long COVID patients who experienced relief of their symptoms after taking the treatment, which is currently only authorized for high-risk people early after onset of COVID symptoms.
As many as 30% of people infected by the coronavirus are believed to develop long COVID, a condition that can last for several months with symptoms including fatigue, rapid heartbeat, shortness of breath, chronic pain, brain fog and muscle weakness. It affects people who have had both mild and severe COVID-19, including children, and can be severe enough to keep people out of work.
In a report published this week ahead of peer review, University of California, San Francisco (UCSF) researchers detailed cases of three patients who developed long-term symptoms after COVID-19 infections.
In two of the cases, the patients "were able to access Paxlovid antiviral therapy and feel that their long COVID symptoms improved substantially," said Dr. Michael Peluso, whose was published online on Research Square."
https://news.yahoo.com/evidence-mounts-study-...31063.html
Maybe Dr. JPoTaderHead can give us is medical opinion?
If little Todos does one more, they are tied. With the two mentioned below that said their long COVID symptoms improved substantially, what does that mean? Did it ever go away?
Evidence mounts for need to study Pfizer's Paxlovid for long COVID - researchers say - Thu, May 5, 2022, 5:15 PM
CHICAGO (Reuters) - Additional reports of patients with long COVID who were helped by Pfizer Inc's oral antiviral treatment Paxlovid offer fresh impetus for conducting clinical trials to test the medicine for the debilitating condition, U.S. researchers said on Thursday.
Three new case studies follow earlier reports of long COVID patients who experienced relief of their symptoms after taking the treatment, which is currently only authorized for high-risk people early after onset of COVID symptoms.
As many as 30% of people infected by the coronavirus are believed to develop long COVID, a condition that can last for several months with symptoms including fatigue, rapid heartbeat, shortness of breath, chronic pain, brain fog and muscle weakness. It affects people who have had both mild and severe COVID-19, including children, and can be severe enough to keep people out of work.
In a report published this week ahead of peer review, University of California, San Francisco (UCSF) researchers detailed cases of three patients who developed long-term symptoms after COVID-19 infections.
In two of the cases, the patients "were able to access Paxlovid antiviral therapy and feel that their long COVID symptoms improved substantially," said Dr. Michael Peluso, whose was published online on Research Square."
https://news.yahoo.com/evidence-mounts-study-...31063.html
Maybe Dr. JPoTaderHead can give us is medical opinion?
(0)
(0)
